ontunisertib
Small molecule
Evidence outlook
Fibrostenosing Crohn's Disease: topline reported 2026-10-01
The sponsor reported topline results on 2026-10-01 (STENOVA open-label extension topline of ontunisertib in fibrostenosing Crohn's disease). The announcement is listed under Regulatory events.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
STENOVA NCT05843578 · Crohn's Disease Registry: NCT05843578 | 2 | Number of participants with adverse events (Part A and B) (From Screening to Week 48); Number of participants with abnormal clinical laboratory values (Part A and B) (From Screening to Week 48); Number of participants with abnormal ECG parameters (Part A and B) (From Screening to Week 48); Number of participants with abnormal vital signs (Part A and B) (From Screening to Week 48); Number of participants with abnormal physical exams (Part A and B) (From Screening to Week 48); Number of participants with abnormal 2D-echocardiography (Part A and B) (From Screening to Week 48) 2026-06-20 | Results not posted; external-source review pending | not yet graded | link ↗ |
View 1 more trial
NOV-ERA NCT07683325 · Crohn's Disease Registry: NCT07683325 | 2 | Proportion of participants achieving endoscopic passability of the ileal index stricture (At week 24) 2028-12-31 | In progress: results expected 31 Dec 2028 | not yet graded | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 2 (2)
What this study did
What this study did
Phase 1 (4)
What this study did
What this study did
What this study did
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(2 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow ontunisertib to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent